BBC Congress October ICC Ghent MODULATING THE BRAIN: FACTS, FICTION, FUTURE

BBC Congress 2014 “MODULATING THE BRAIN: FACTS, FICTION, FUTURE” PHARMACOLOGICAL MODULATION ELECTRICAL MODULATION BEHAVIOURAL MODULATION COGNITION, MO...
5 downloads 0 Views 1MB Size
BBC Congress 2014 “MODULATING THE BRAIN: FACTS, FICTION, FUTURE” PHARMACOLOGICAL MODULATION ELECTRICAL MODULATION BEHAVIOURAL MODULATION COGNITION, MOVEMENT DISORDERS, EPILEPSY, HEADACHES, PAIN & PSYCHIATRIC DISORDERS

4 October 2014 ICC Ghent

 

1  

Clinical & Basic Neuroscience Societies (N=19) ↘ ↘

Patients Associations (N= 17) ↓ ↓ ↓ ↓

Belgian EDAB Rep. (N=1) ↙ ↙

↓ ↓ ↓ ↓



Industrial Stakeholders (N=11)

Belgian Brain Council ↓↓ Board of Directors (N=22)

(linguistic parity)

Organizing Committee Belgian Brain Congress 2014 Dirk VAN ROOST (Neurosurgery - chair) Wim FIAS (Neurosciences co-chair) Rebecca MÜLLER (Ups & Downs) Franco GIANNI (Together for the Brain) Steven LAUREYS (Neurology) Amelia LE ROY (Brain tumours)

Roland POCHET (Neurosciences - treasurer) Jean SCHOENEN (Neurology - coordinator) Bart STULENS (Medtronic) Charles VAN DER STRATEN (MS League) Paul VERBANCK (Psychiatry) Rufin VOGELS (Neurosciences)

Administrative Secretary

Congress Organizing Company

Marina Van Oirschot

A+A Communication bvba/sprl

[email protected] Tel: +32 3 322 28 50 - fax: +32 3 322 45 14

[email protected] Tel: +32 9 220 56 29 – Fax: +32 9 270 3 270

Belgian Brain Congress 2014  

2  

After Genval (2006), Ostend (2008), Brussels (2010) and Liège (2012), Ghent welcomes the 5th edition of the Belgian Brain Congress. By definition, the BBC congresses aim to be multidisciplinary even “transdisciplinary”, meaning they are evolving simultaneously between, through and beyond disciplines and focus on helping to understand the complexity of the brain and brain diseases. During the last decade it has become evident that activity of brain areas and circuits can be modulated by a number of different so-called neuromodulatory methods ranging from electrical stimulation to drug treatment and behavioural therapies. Neuromodulation has opened novel perspectives to alleviate neurological and psychiatric symptoms in various brain disorders and dysfunctions. Neuromodulation has also raised much interest in the general population because it has the potential to modify function and performance of the normal human brain. It seems timely therefore to present and discuss comprehensively the advantages and limitations of the different neuromodulation methods in brain disorders and to have an overview on present knowledge of the mechanisms of action of these methods. It is also a crucial societal issue to know whether neuromodulation methods should be recommended for cognitive enhancement and what the risks of such interventions are. Novel therapeutic treatment of nervous system disorders represents one of the most significant and unmet needs in modern medicine. Deep-brain Stimulation (DBS) strategies have been shown to be remarkably effective for treating a number of neurological and psychiatric conditions including Parkinson’s Disease, dystonia, essential tremor, epilepsy, chronic pain, major depression, migraines, as well as a number of other conditions. The BBC 2014 congress aims at providing this information to health providers, but also to patients and caregivers, in a transdisciplinary program spanning from the basic to the clinical neurosciences, and to medico-social matters. The Ghent BBC 2014 Congress, as a participant of the “2014 Year of the Brain”, will be launched as a forum in which European researchers and clinicians will communicate and interact with a large panel of stakeholders including patients associations and policy makers interested in this innovative field. Target audience:

 



Health care professionals interested in neurological issues



Neuroscientists and students



Members of patients & family associations



Policy makers



Health journalists



Industrial stakeholders

3  

Programme 09.00 – 10.00

Main Auditorium PLENARY SESSION 1 (chairpersons: R. Vogels, J. Schoenen) ELECTRICAL NEUROMODULATION

09.00 – 09.30

Mechanisms of action of invasive neurostimulation Nikos Logothetis, Tübingen

09.30 – 10.00

Mechanisms of action of non-invasive neurostimulation Walter Paulus, Göttingen

10.00 – 11.00

Forum POSTER Session 1 Exhibitions, Coffee

Breakout room Van Eyck Satellite Symposium 1 Neurotransmitter imaging: a tool for detecting and monitoring brain modulation (General Electric)

Breakout room VanderGoes TOPICAL SESSION 1

Breakout room Van Eyck TOPICAL SESSION 2

(chairpersons: P. Santens, S. Henri)

(chairpersons: K. Audenaert, R. Müller)

11.00 – 11.20

Movement disorders Alain Maertens de Noordhout, Liège

Obsessive compulsive disorder Bart Nuttin, Leuven

11.20 – 11.40

Epilepsy Dirk Van Roost - Paul Boon, Ghent

Depression Chris Baeken, Ghent-Brussels

11.40 -12.00

Pain

Consciousness disorders

Benoît Pirotte, Brussels

Steven Laureys, Liège

12.00 – 12.20

Tinnitus Dirk De Ridder, Antwerp

Stroke Yves Vandermeeren, Mont-Godinne

12.20 – 12.40

Headache Delphine Magis, Liège

Addiction Jürgen Voges, Magdeburg

11.00 – 12.40

Forum POSTER Session 2 12.40 – 14.00 Exhibitions, Lunch

14.00 – 15.00

Breakout room Van Eyck Satellite Symposium 2 The Concept of Continuous Evidence based Neuromodulation (Medtronic SA/NV)

Main Auditorium PLENARY SESSION 2 (chairpersons: W. Fias, J. De Keyser) BEHAVIOURAL NEUROMODULATION

 

4  

14.00

Critical appraisal of cognitive enhancement Nicole Wenderoth, Zürich

14.30

Mechanisms of action of behavioural modulation Hubert Dinse, Bochum

15.00- 17.00

Forum Exhibitions, Coffee Breakout room VanderGoes 15.00 – 16.00 Satellite Symposium 3 OnabotulinumtoxinA as a biologic neuromodulator – motor effect ok, but a sensory effect? (Allergan)

16.30 – 18.00

Breakout room Van Eyck 15.00 – 16.30 Medico-Social Workshop Ethics, economics and quality of life in neuromodulation anno 2014-Year of the Brain. Chairpersons: Gianni Franco and Mary Baker, European Brain Council

Main Auditorium TOPICAL SESSION 3: (Chairpersons: A. Ivanoiu, G. Moonen)

16.30 – 16.50 Hypnosis Marie-Elisabeth Faymonville, Liège 16.50 – 17.10 Cognitive revalidation Steve Majerus, Liège 17.10 – 17.30 Neurofeedback Bettina Sorger, Maastricht 17.30 – 17.50 Mindfulness Rudi De Raedt, Ghent

17.50 – 18.20 PLENARY SESSION 3 Perspectives in neuromodulation Optogenetics Wim Vanduffel, Leuven-Boston 18.20 -18.30

Poster Prizes

18:30 – 19.30 Farewell cocktail & Musical Neuromodulation.  

For last minute changes, please consult the website: http://www.belgianbraincouncil.be/congress2014/index.html

 

5  

15.00  –  16.30  

Medico-­‐Social  Workshop  Ethics,economics  and  quality  of  life  in   neuromodulation  anno  2014-­‐Year  of  the  Brain.  CO-­‐CHAIRS:  Gianni  Franco  and   Mary  Baker,  Past-­‐President  European  Brain  Council    

Breakout  room  Van  Eyck     (co-­‐chairpersons:A.  Leroy,  M.  Mormal,  Ch.  van  der  Straten)       HOW  CAN  NEUROMODULATION   Bruno  KASCHTEN,  Belgian  Society  for   IMPROVE  QUALITY  OF  LIFE?     Stereotactic  and  Functional   Neurosurgery  president,  Neurosurgeon   ULg,   Frederic  SUPIOT,  Neurologist  ULB.     SOCIO-­‐ETHICAL,  ECONOMICAL  AND   Ignaas  Devisch  (Philosopher,  UGent)     POLITICAL  POINTS  OF  VIEW.   Dominique  Jacquemin  (Ethics,  UCL)   Jean  Noel  MISSA  (Philosopher-­‐  sociology,   ULB)     Jo  Vandeurzen  (Flemish  Minister  for   Welfare,  Public  Health  and  Family)   Monica  De  Coninck  (  Federal  Minister  of   Employment)     THE  REALITY  OF  LIFE  IN  BELGIUM   R.  Deridder  (Director  General  INAMI-­‐ RIZIV)           DEBATE  with  the  assembly,  only  via  questions  from  the  floor  (collected  before  the   meeting  on  paper  sheets)               Satellite General Electric Healthcare Symposium 1 Breakout room Van Eyck

10.00  –  11.00  

Neurotransmitter  imaging:  a  tool  for  detecting  and  monitoring  brain   modulation  

1)    10  years  of  Datscan®  in  Belgium     Interactive  session  between  a  neurologist  and  a  nuclear  medicine  physician  on  specific   clinical  cases.     Koen  Van  Laere  (KUL),  Michel  Gonce  (CHR  Liège)   2)    Early  Diagnosis  of  Alzheimer’s  disease,  contribution  of  amyloid  plaques  imaging.     Presentations  of  last  development  and  data  on  Flutemetamol  PET  imaging.    

Adrian  Ivanoiu  (UCL)    

 

6  

Satellite Medtronic SA/NV Symposium 2 Breakout room Van Eyck

12:40  –  14.00  

Deep  brain  stimulation  at  an  earlier  stage  of  Parkinson’s  disease    

CHAIR:  Günther  Deuschl  (D)     1)   Neurostimulation  for  PD  with  early  motor  complications:                                  Michael  Schüpbach  (Bern,CH)       2)   Early  application  of  DBS,  clinical  and  ethical  aspects:                                Pierre  Pollak  (Genève,CH)     3)   Stimulation  of  the  STN  at  an  early  stage  of  Parkinson’s  disease:                                Günther  Deuschl  (Kiel,D)       Case-­‐based  presentations  and  interactive  discussion  with  audience.  

Satellite Allergan SA/NV Symposium 3 Breakout room VanderGoes 15:00  –  16.00   “OnabotulinumtoxinA  in  the  neurologist’s  patients  –  not  only  motor  effects,  

but  also  sensory  effects  ?”  

    CO-­‐CHAIRS  :  Prof  K.Paemeleire  (UG)  &  Prof  J.Schoenen(Ulg)     Introduction:  Chronic  Migraine  recommendations  of  the  Belgian  Headache  Society     Jean  Schoenen  (Ulg)     1)    Science  of  onabotA’s  neuromodulating  mechanism  of  action:  an  accepted  motor   effect  but  a  surprising  sensory  effect  ?   Oliver  Dolly  (Dublin,IRL)         2)    OnabotA  neuromodulation  in  clinical  management  of  chronic  migraine   symptoms.     Michel  Vandenheede  (CHC  Liège)     3)    OnabotA  neuromodulation  in  clinical  management  of  chronic  post-­‐stroke   symptoms.   Kristine  Oostra  (UZ  Gent)  

 

7  

Posters  &  abstracts:   Free  communications  are  very  wellcome  on  any  basic  or  clinical  neuroscience  topic.  They  will   presented  as  posters.  There  will  be  poster  discussions  and  a  prize  for  the  3  best  posters.     Deadline  for  poster  submission:  July  1st,  2014     Maximum  Poster  size:  100  cm  large  x  120  cm  high  (portrait).     Posters  should  be  hung  on  the  numbered  poster  boards  between  8  :15  and  8  :45  hrs  and  visible  the   whole  day.  There  are  2  dedicated  poster  discussion  sessions  from  10-­‐11hrs  and  12.40-­‐14hrs.       Each  poster  abstract  should  contain  a  short  comment  (max  150  words)  on  the  significance  of  the   research  work  presented  in  the  abstract  and  the  potential  relevance  for  patient  care.   Abstracts  to  be  submitted  either  in  English,  Dutch  or  French  (one  language).     All  accepted  abstracts  will  be  published  and  accessible  via  the  Frontiers  website  (see     http://www.frontiersin.org/events/Belgian_Brain_Council_2014MODULATING_THE_BRAIN_FACTS_F ICTION_FUTURE/2177       The  printed  abstract  book  will  contain:   • Abstracts  of  invited  speakers  (250  words)   • Short  comments  in  Dutch  and  French  on  the  significance  and  the  potential  relevance  for   patient  care  of  the  research  work  presented  in  each  poster  abstract   Poster  Prizes   A  jury  composed  of  Jacques  De  Keyser  (VUB),  Wim  Fias  (UGent),  Rachelle  Franzen  (ULg),  Rebecca   Muller  (Ups  &Downs)  and  Jan  Versijpt  (VUB)  will  select  during  the  congress  the  three  best  posters   (quality  of  the  discussion  during  poster  viewing,  innovation  of  the  research/results,  design  of  the   poster).   The  3  winners  will  be  interviewed  and  video-­‐recorded  for  podcasting.  The  recipients  of  the  3  Prizes   (250  €  each)  will  be  announced  at  the  closing  ceremony.   Only  poster  authors  who  are  present  at  the  closing  ceremony  will  receive  the  Prize  (presence   mandatory).  In  case  presenters  of  the  best  posters  are  absent,  the  2nd  best  will  receive  the  prize.    

  Webcasts   Webcasts  will  be  produced  during  the  congress.  Invited  speakers,  selected  poster  presenters  and   representatives  from  the  patients’  associations  will  be  asked  to  briefly  summarize  their  message  and   significance  for  understanding  brain  functions  and  managing  its  dysfunctions.  These  webcasts  will  be   posted  on  the  BBC  website  at  http://www.belgianbraincouncil.be       Jean  Schoenen  &  Rufin  Vogels     on  behalf  of  the  organizing  committee.    

 

 

8  

Participants’ fee (to be completed on line: see: http://www.belgianbraincouncil.be/congressII/regist.php Category

 

Until Aug. 16 125€

After Aug. 17

On site

150€

175€

60€

75€

100€

200€

250€

300€

A

Academic & MD

B

Other health professionals

C

Industry

D

Resident & PhD below 30

0€

0€

25€

E

Patient Associations member

0€

0€

25€

9  

Practical information: Date:

4 October 2014

Venue:

ICC GHENT Citadelpark B-9000 GHENT Tel. +32 (0)9 242 89 00 http://www.iccghent.com/typo/index.php

 

10  

How to reach the ICC BY CAR

Using PUBLIC TRANSPORTATION (train)

Coming from Kortrijk, Lille, Paris: E17 direction Antwerp Take the Exit 'Gent Centrum' (see below) Coming from Brussels: E40 Brussels - Ostend Follow E17, direction Antwerp at the Zwijnaarde traffic junction Take the Exit 'GentCentrum' (see below) Coming from Ostend, London E40 Ostend – Brussels Follow E17, direction Antwerp at the Zwijnaarde traffic junction Take the Exit 'GentCentrum' (see below) At the exit Gent Centrum: Follow the Exit ‘Andere richtingen’ (You are now leaving the highway) Turn left at the traffic lights beneath the overpass You are now entering the St.-Lievenslaan Follow direction S.M.A.K. at the third traffic lights Drive along the S.M.A.K. museum (on your right hand side) 50 m further you will find the ICC International Convention Centre Ghent on your right hand side.

Coming from Lille, Paris: Take a train to Brussels, change at Brussels Midi and take an IC train to Ostend or Knokke-Blankenberge. Ghent is the first stop (GentSint-Pieters). Coming from Ostend, London: Take an IC train to Brussels. Ghent is the second stop (Gent-Sint-Pieters) (first stop is Bruges). On your arrival at the Gent-SintPieters Railway Station you can either walk to the ICC (1.1 km = 15 minutes - to walk click here) or take bus 70 or 71 or 72 or 76 (bus station platforms 15 & 16) that all stop at the Ledeganckstraat directly opposite the entrance of the ICC. All of these as well as the lines 73 and 74 drive from the Ledeganckstraat to the Gent-SintPieters Railway Station.

 

www.belgianrail.be (train) www.delijn.be (bus)

11  

Suggest Documents